期刊文献+

我院ICU 2008年和2009年药品使用的ABC分析 被引量:3

Analysis of Medication in ICU in Our Hospital in 2008 and 2009 with ABC Methods
原文传递
导出
摘要 目的调查新疆维吾尔自治区中医院ICU 2008年和2009年药品使用情况,为临床合理用药及医院内部科室药品比例增减提供参考。方法采用ABC分析法对药品的品种及金额进行统计分析,并对A类药品进行重点分析。结果 2009年A类药品共计22种,金额百分比72.74%,B类药品23种,金额百分比17.45%,C类药品173种,金额百分比9.81%;2008年A类药品共计32种,金额百分比72.51%,B类药品33种,金额百分比18.23%,C类药品203种,金额百分比9.26%。其中A类药品均高度集中在抗菌药物。结论 ICU用药存在不合理现象,应加强抗菌药物及中药注射剂的管理,促进合理用药。 OBJECTIVE To investigate the medication in ICU in traditional Chinese medical hospital of Xinjiang Uygur autonomous region in 2008 and 2009 for providing a reference for rational use of medicines and increasing or decreasing drug rate.METHODS Statistical analysis of drug of variety amount of money with ABC,and emphasis on A species.RESULTS In 2009,the kinds of A species were 22 and the amount of money percentage were 72.74%,the kinds of B species were 23 and the amount of money percentage were 17.45%,and the kinds of C species were 173 and the amount of money percentage were 9.81%.In 2008,the kinds of A species were 32 and the amount of money percentage were 72.51%,the kinds of B species were 33 and the amount of money percentage were 18.23%,and the kinds of C species were 203,and the amount of money percentage were 9.26%.And A species concentrate mainly on antibacterials.CONCLUSION There was unreasonable medication,therefore,it should be strengthened that the management of antibacterials and injection of traditional Chinese medicine and help forward reasonable medication.
出处 《中国现代应用药学》 CAS CSCD 北大核心 2011年第2期178-181,共4页 Chinese Journal of Modern Applied Pharmacy
关键词 ABC分析法 ICU 用药分析 ABC methods ICU analysis of medication
  • 相关文献

参考文献5

二级参考文献20

  • 1陈立军,江荣林,毛文炜,邵海燕,周仁芳,陈军.莫西沙星治疗106例社区获得性肺炎病人的前瞻性研究[J].中国新药与临床杂志,2005,24(1):14-17. 被引量:30
  • 2李耘,李家泰,王进,中国细菌耐药监测研究组.中国重症监护病房细菌耐药性监测研究[J].中华检验医学杂志,2004,27(11):733-738. 被引量:122
  • 3MAN I, MURPHY J, FERGUSON J. Fluoroquinolone phototoxicity: a comparison of moxifloxacin and lomefloxacin in normal volunteers [J]. Antimicrobial Chemotherapy, 1999, 43 (Suppl B) : 77-82.
  • 4Fabrizi F, Dixit V, Martin P. Meta - analysis: the adjuvant role of thymopentin on immunological response to hepatitis B virus vaccine in end stage renal disease[JJ. Aliment Pharmaeol Ther, 2006,23 (11): 1559.
  • 5Nesterova IV.Modem Immunotherapy in Clinical Medicine: Present and Future[J] .Russ J Immunol, 1999, Dec,4(4) :322 - 326.
  • 6Siemion I Z, Kluczyk A, Cebrat M. The peptide molecular links between the central nervous and the immune systems[ J]. Amino Acids,2005,29 (3) : 161.
  • 7Novoselova EG, Lunin SM, Khrenov MO, et al. Effect of thymopentin an production of cytokines, heat shock proteins,and NF- kappaB signaling proteins[J]. Izv Akad Nank Ser Biol,2008, Jul- Aug, (4):422- 8.
  • 8胡明礼.国内莫西沙星不良反应文献分析[J].药学服务与研究,2007,7(4):281-283. 被引量:41
  • 9J. C. Marshall. Clinical trials of mediator-directed therapy in sepsis: what have we learned?[J] 2000,Intensive Care Medicine(1):S075~S083
  • 10H. -D. Volk,P. Reinke,D. Krausch,H. Zuckermann,K. Asadullah,J. M. Müller,W. -D. D?cke,W. J. Kox. Monocyte deactivation-rationale for a new therapeutic strategy in sepsis[J] 1996,Intensive Care Medicine(4):S474~S481

共引文献172

同被引文献29

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部